Self-reported compliance with drug therapy during the first SARS-CoV-2 Italian lockdown in patients with respiratory disease.

IF 1.7 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Annali dell'Istituto superiore di sanita Pub Date : 2022-04-01 DOI:10.4415/ANN_22_02_04

Rosastella Principe, Loreta Di Michele, Alfredo Sebastiani, Daniela Savi, Claudio Perrone, Giovanni Galluccio, Claudia Giacomozzi

{"title":"Self-reported compliance with drug therapy during the first SARS-CoV-2 Italian lockdown in patients with respiratory disease.","authors":"Rosastella Principe, Loreta Di Michele, Alfredo Sebastiani, Daniela Savi, Claudio Perrone, Giovanni Galluccio, Claudia Giacomozzi","doi":"10.4415/ANN_22_02_04","DOIUrl":null,"url":null,"abstract":"Background: Low compliance with drug therapy in patients with chronic respiratory diseases was a well-known issue even before the coronavirus pandemic, but its causes are not yet fully defined.Objective: To verify the adherence to drug therapy in patients with respiratory disease during the COVID-19 pandemic.Methods: From June to September 2020, about 700 patients of the Forlanini Hospital who had been unmonitored during the March-May 2020 lockdown in Italy received a questionnaire during the pneumological check-up based on self-reported information on compliance with therapy during lockdown.Results: 284 out of the 418 returned questionnaires could be used in this study: 179 patients (63.0%) responded positively to the continuation of therapy, 18 (6.3%) reduced the dosage of their medication and 82 (28.9%) interrupted the therapy.Conclusions: The low percentage of patients that reduced their drug dosage may be due to an increased awareness of drug treatment benefits, and may also be ascribed to the Government healthcare strategy during lockdown.","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":"58 2","pages":"93-99"},"PeriodicalIF":1.7000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annali dell'Istituto superiore di sanita","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4415/ANN_22_02_04","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 1

Abstract

Background: Low compliance with drug therapy in patients with chronic respiratory diseases was a well-known issue even before the coronavirus pandemic, but its causes are not yet fully defined.

Objective: To verify the adherence to drug therapy in patients with respiratory disease during the COVID-19 pandemic.

Methods: From June to September 2020, about 700 patients of the Forlanini Hospital who had been unmonitored during the March-May 2020 lockdown in Italy received a questionnaire during the pneumological check-up based on self-reported information on compliance with therapy during lockdown.

Results: 284 out of the 418 returned questionnaires could be used in this study: 179 patients (63.0%) responded positively to the continuation of therapy, 18 (6.3%) reduced the dosage of their medication and 82 (28.9%) interrupted the therapy.

Conclusions: The low percentage of patients that reduced their drug dosage may be due to an increased awareness of drug treatment benefits, and may also be ascribed to the Government healthcare strategy during lockdown.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

意大利首次SARS-CoV-2封锁期间呼吸道疾病患者自我报告的药物治疗依从性

背景:早在冠状病毒大流行之前，慢性呼吸系统疾病患者对药物治疗的依从性低就是一个众所周知的问题，但其原因尚未完全确定。目的:验证新冠肺炎大流行期间呼吸系统疾病患者药物治疗依从性。方法:2020年6月至9月，对意大利福拉尼尼医院(Forlanini Hospital)约700名在2020年3月至5月封城期间未接受监测的患者，根据封城期间治疗依从性的自我报告信息，在肺炎检查期间填写问卷。结果:在收到的418份问卷中，有284份可用于本研究，179名患者(63.0%)对继续治疗有积极反应，18名患者(6.3%)减少了药物剂量，82名患者(28.9%)中断了治疗。结论:减少药物剂量的患者比例较低可能是由于对药物治疗益处的认识提高，也可能是由于政府在封锁期间的卫生保健战略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Annali dell'Istituto superiore di sanita PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

3.80

自引率

4.80%

发文量

审稿时长

>12 weeks

期刊介绍： Annali dell’Istituto Superiore di Sanità is a peer reviewed quarterly science journal which publishes research articles in biomedicine, translational research and in many other disciplines of the health sciences. The journal includes the following material: original articles, reviews, commentaries, editorials, brief and technical notes, book reviews. The publication of Monographic Sections has been discontinued. In case you wish to present a small number of coordinated contributions on specific themes concerning priorities in public health, please contact the Editorial office. The journal is in English.